Vitamin D and Calcium for Fracture Prevention: What the Evidence Actually Shows
A comprehensive JAMA meta-analysis found that vitamin D alone does not reduce fracture risk, but daily combined vitamin D and calcium supplementation reduced hip fractures by 16%.
Read the original article at JAMA Network OpenKairos™'s Take
Kairos™'s perspective on this story
A 2019 systematic review and meta-analysis published in JAMA Network Open examined the fracture prevention evidence for vitamin D and calcium supplementation across multiple randomized clinical trials. The findings drew an important line: vitamin D supplementation alone — across 11 trials with 34,243 participants — showed no significant reduction in hip fracture or total fracture risk. However, when vitamin D was combined with calcium in daily doses, the picture changed. Across 6 trials with 49,282 participants, the combination was associated with a statistically significant 16% reduction in hip fracture risk.
This distinction matters because vitamin D supplements are among the most widely used over-the-counter products in the United States, often taken without calcium and without clear evidence of benefit for bone endpoints when used alone. The study suggests that the combination is what matters — and that dosing consistency (daily rather than intermittent large doses) is important for efficacy.
Why This Matters for Midlife Health
During and after the menopausal transition, many women begin taking supplements to protect their bone health. This meta-analysis helps separate evidence-based strategies from wishful thinking. Vitamin D alone is not a substitute for a comprehensive bone health plan. The combination with calcium, adequate protein intake, weight-bearing exercise, and — when indicated — pharmacological treatment is what moves the needle. Knowing what works and what does not allows women in midlife to invest their effort where the evidence points.
The Tracking Connection
Supplement use is one of the most common things people do for their health and one of the least tracked. Kairos™ lets users log supplements alongside lab results (including vitamin D levels and calcium), DXA results, and symptoms. Over time, this creates a picture of whether your supplementation strategy is actually reflected in your clinical numbers — rather than assuming a daily pill is enough. Evidence-based decisions require evidence, and that starts with tracking.
Ready to start tracking?
Kairos™ tracks, scores, and interprets the symptoms of midlife hormonal change — for both women and men.
Get StartedMore from the newsroom
SWAN Study: Bone Loss Accelerates Sharply During the Menopause Transition
The landmark SWAN longitudinal study showed that bone mineral density remains stable in early perimenopause but declines sharply in late perimenopause — about 2% per year — continuing into early postmenopause.
The FREEDOM Trial: Denosumab Reduces Vertebral Fractures by 68% in Postmenopausal Women
The landmark FREEDOM trial published in NEJM showed that denosumab, a monoclonal antibody, significantly reduced vertebral, hip, and nonvertebral fractures in women with osteoporosis over 3 years.
The Treatment Gap in Osteoporosis: Fewer Than 20% of High-Risk Patients Receive Care
A comprehensive review documents the growing osteoporosis treatment gap — with diagnosis rates below 20% and post-fracture treatment rates declining despite effective therapies being available.